At the 2025 American Association for Bronchology and Interventional Pulmonology (AABIP) Conference, Eon’s Chief Medical Officer, Dr. Scott Skibo, presented research on risk progression in pulmonary nodules traditionally classified as “low-risk.” These findings challenge long-standing assumptions and underscore the importance of systematic surveillance.

 Eon AABIP 2025 Research Poster